Sers C - Search Results

1

Mutation-specific effects of NRAS oncogenes in colorectal cancer cells.

Kuhn N, Klinger B, Uhlitz F, Sieber A, Rivera M, Klotz-Noack K, Fichtner I, Hoffmann J, Blüthgen N, Falk C, Sers C, Schäfer R. Kuhn N, et al. Among authors: sers c. Adv Biol Regul. 2021 Jan;79:100778. doi: 10.1016/j.jbior.2020.100778. Epub 2020 Dec 31. Adv Biol Regul. 2021. PMID: 33431353

2

Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.

Tchernitsa OI, Zuber J, Sers C, Brinckmann R, Britsch SK, Adams V, Schäfer R. Tchernitsa OI, et al. Among authors: sers c. Oncogene. 1999 Sep 23;18(39):5448-54. doi: 10.1038/sj.onc.1202987. Oncogene. 1999. PMID: 10498898

3

A genome-wide survey of RAS transformation targets.

Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schäfer R. Zuber J, et al. Among authors: sers c. Nat Genet. 2000 Feb;24(2):144-52. doi: 10.1038/72799. Nat Genet. 2000. PMID: 10655059

4

Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.

Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schäfer R, Sers C. Wiechen K, et al. Among authors: sers c. Am J Pathol. 2001 Nov;159(5):1635-43. doi: 10.1016/S0002-9440(10)63010-6. Am J Pathol. 2001. PMID: 11696424 Free PMC article.

5

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.

Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schröder K, Gontarewicz A, Schäfer R. Sers C, et al. Oncogene. 2002 Apr 25;21(18):2829-39. doi: 10.1038/sj.onc.1205377. Oncogene. 2002. PMID: 11973642

6

Gene expression profiling in RAS oncogene-transformed cell lines and in solid tumors using subtractive suppression hybridization and cDNA arrays.

Sers C, Tchernitsa OI, Zuber J, Diatchenko L, Zhumabayeva B, Desai S, Htun S, Hyder K, Wiechen K, Agoulnik A, Scharff KM, Siebert PD, Schäfer R. Sers C, et al. Adv Enzyme Regul. 2002;42:63-82. doi: 10.1016/s0065-2571(01)00024-3. Adv Enzyme Regul. 2002. PMID: 12123707 No abstract available.

7

Dissection of signal-regulated transcriptional modules by signaling pathway interference in oncogene-transformed cells.

Schäfer R, Tchernitsa OI, Zuber J, Sers C. Schäfer R, et al. Among authors: sers c. Adv Enzyme Regul. 2003;43:379-91. doi: 10.1016/s0065-2571(02)00040-7. Adv Enzyme Regul. 2003. PMID: 12791398 Review. No abstract available.

8

Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells.

Tchernitsa OI, Sers C, Zuber J, Hinzmann B, Grips M, Schramme A, Lund P, Schwendel A, Rosenthal A, Schäfer R. Tchernitsa OI, et al. Among authors: sers c. Oncogene. 2004 Jun 3;23(26):4536-55. doi: 10.1038/sj.onc.1207585. Oncogene. 2004. PMID: 15064704

9

Prediction of cis-regulatory elements of coregulated genes.

Kiełbase SM, Blüthgen N, Sers C, Schäfer R, Herzel H. Kiełbase SM, et al. Among authors: sers c. Genome Inform. 2004;15(1):117-24. Genome Inform. 2004. PMID: 15712115

10

Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanisms.

Lotz K, Kellner T, Heitmann M, Nazarenko I, Noske A, Malek A, Gontarewicz A, Schäfer R, Sers C. Lotz K, et al. Among authors: sers c. Int J Cancer. 2005 Oct 10;116(6):894-902. doi: 10.1002/ijc.21127. Int J Cancer. 2005. PMID: 15856468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters